Capricorn Fund Managers LTD Tarsus Pharmaceuticals, Inc. Transaction History
Capricorn Fund Managers LTD
- $277 Million
- Q4 2025
A detailed history of Capricorn Fund Managers LTD transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Capricorn Fund Managers LTD holds 21,982 shares of TARS stock, worth $1.59 Million. This represents 0.57% of its overall portfolio holdings.
Number of Shares
21,982
Previous 240,020
90.84%
Holding current value
$1.59 Million
Previous $14.3 Million
88.87%
% of portfolio
0.57%
Previous 5.45%
Shares
2 transactions
Others Institutions Holding TARS
# of Institutions
234Shares Held
44.4MCall Options Held
51.6KPut Options Held
15.8K-
Black Rock Inc. New York, NY3.27MShares$236 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.18MShares$229 Million2.52% of portfolio
-
Deep Track Capital, LP Greenwich, CT3MShares$217 Million5.63% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.67MShares$192 Million5.1% of portfolio
-
Tang Capital Management LLC San Diego, CA2.45MShares$177 Million6.63% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.92B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...